INTERCEPT eNews Archive
INTERCEPT eNews Features
|
|
-
Product updates and announcements
-
Events, webinars and congresses
-
INTERCEPT in the news
-
INTERCEPT customer profiles
-
Industry news and events
-
Highlights of Industry publications
-
Pathogen spotlight
|

|
PAST ISSUES
2011
December - INTERCEPT Chosen for Illuminator Contracts in Russia
November - Cerus Awarded New Supply Agreement with French National Blood Service
October - France : Afssaps to Replace Methylene Blue with INTERCEPT and SD Plasma
September - Swiss Publication Reports on Safety, Efficacy, and Economics of Double Dose INTERCEPT Platelets
August - 2010 Dengue Outbreak Resulted in Significant Loss of Australian Blood Supply
July - Child's Death Linked to Bacterial Contamination in Transfused Platelets
June - E.coli Outbreak Puts Spotlight on Blood Availability
May - German Publication Confirms Efficacy of INTERCEPT Platelets
April - TESSI Study Published in the British Journal of Haematology
March - First German Center Begins Routine use of INTERCEPT Plasma
February - TSR.ch interviews Swiss Red Cross in Lausanne regarding INTERCEPT Platelets

2010
November - INTERCEPT Plasma Receives Swiss Approval
October - French Study Affirms Use of INTERCEPT Platelet System
September - Swiss Study Supports INTERCEPT Platelets
July - ISBT Highlights and Blood Safety News
June - AABB Calls for Deferral of CFS Patients
May - XMRV Inactivation by INTERCEPT Confirmed
April - Swiss Deploy INTERCEPT Platelets and Expand Regulatory Claims
March - INTERCEPT Red Cell Program Moves Forward
January - TESSI Trial Affirms 7-Day INTERCEPT Platelet Efficacy
Please Note: Archived eNews publications are not updated; therefore, information contained in the archived material may be out of date or no longer valid.
|